Binding and Dynamics Demonstrate the Destabilization of Ligand Binding for the S688Y Mutation in the NMDA Receptor GluN1 Subunit

被引:1
|
作者
Chen, Jake Zheng [1 ,2 ]
Church, William Bret [1 ]
Bastard, Karine [1 ]
Duff, Anthony P. [3 ]
Balle, Thomas [1 ,2 ]
机构
[1] Univ Sydney, Fac Med & Hlth, Sydney Pharm Sch, Camperdown, NSW 2006, Australia
[2] Univ Sydney, Brain & Mind Ctr, Camperdown, NSW 2050, Australia
[3] Australian Nucl Sci & Technol Org, Natl Deuterat Facil, New Illawarra Rd, Lucas Heights, NSW 2234, Australia
来源
MOLECULES | 2023年 / 28卷 / 10期
关键词
molecular dynamics; NMDA receptor; membrane protein; ligand binding; encephalopathies; INTELLECTUAL DISABILITY; SYNAPTIC PLASTICITY; ACCURATE DOCKING; GRIN1; MUTATIONS; ACTIVATION; PROTEIN; SCHIZOPHRENIA; INHIBITION; GLUTAMATE; MECHANISM;
D O I
10.3390/molecules28104108
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Encephalopathies are brain dysfunctions that lead to cognitive, sensory, and motor development impairments. Recently, the identification of several mutations within the N-methyl-D-aspartate receptor (NMDAR) have been identified as significant in the etiology of this group of conditions. However, a complete understanding of the underlying molecular mechanism and changes to the receptor due to these mutations has been elusive. We studied the molecular mechanisms by which one of the first mutations within the NMDAR GluN1 ligand binding domain, Ser688Tyr, causes encephalopathies. We performed molecular docking, randomly seeded molecular dynamics simulations, and binding free energy calculations to determine the behavior of the two major co-agonists: glycine and D-serine, in both the wild-type and S688Y receptors. We observed that the Ser688Tyr mutation leads to the instability of both ligands within the ligand binding site due to structural changes associated with the mutation. The binding free energy for both ligands was significantly more unfavorable in the mutated receptor. These results explain previously observed in vitro electrophysiological data and provide detailed aspects of ligand association and its effects on receptor activity. Our study provides valuable insight into the consequences of mutations within the NMDAR GluN1 ligand binding domain.
引用
收藏
页数:17
相关论文
共 44 条
  • [1] The pathogenic S688Y mutation in the ligand-binding domain of the GluN1 subunit regulates the properties of NMDA receptors
    Skrenkova, Kristyna
    Song, Jae-man
    Kortus, Stepan
    Kolcheva, Marharyta
    Netolicky, Jakub
    Hemelikova, Katarina
    Kaniakova, Martina
    Krausova, Barbora Hrcka
    Kucera, Tomas
    Korabecny, Jan
    Suh, Young Ho
    Horak, Martin
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [2] Effects of mutations in the NMDA receptor GluN1 subunit on binding and dynamics: a computational approach
    Chen, Zheng
    Church, W. Bret
    Bastard, Karine
    Duff, Anthony P.
    Balle, Thomas
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2021, 77 : C696 - C696
  • [3] Ligand binding domain interface: A tipping point for pharmacological agents binding with GluN1/2A subunit containing NMDA receptors
    Bledsoe, Douglas
    Vacca, Bryanna
    Laube, Bodo
    Klein, Bradley G.
    Costa, Blaise
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 844 : 216 - 224
  • [4] Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors
    Karakas, Erkan
    Simorowski, Noriko
    Furukawa, Hiro
    NATURE, 2011, 475 (7355) : 249 - U170
  • [5] Conformational Analysis of NMDA Receptor GluN1, GluN2, and GluN3 Ligand-Binding Domains Reveals Subtype-Specific Characteristics
    Yao, Yongneng
    Belcher, John
    Berger, Anthony J.
    Mayer, Mark L.
    Lau, Albert Y.
    STRUCTURE, 2013, 21 (10) : 1788 - 1799
  • [6] Positive Modulatory Interactions of NMDA Receptor GluN1/2B Ligand Binding Domains Attenuate Antagonists Activity
    Bledsoe, Douglas
    Tamer, Ceyhun
    Mesic, Ivana
    Madry, Christian
    Klein, Bradley G.
    Laube, Bodo
    Costa, Blaise M.
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [7] Crystal Structure and Pharmacological Characterization of a Novel N-Methyl-D-aspartate (NMDA) Receptor Antagonist at the GluN1 Glycine Binding Site
    Kvist, Trine
    Steffensen, Thomas Bielefeldt
    Greenwood, Jeremy R.
    Mehrzad Tabrizi, Fatemeh
    Hansen, Kasper B.
    Gajhede, Michael
    Pickering, Darryl S.
    Traynelis, Stephen F.
    Kastrup, Jette Sandholm
    Braeuner-Osborne, Hans
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (46) : 33124 - 33135
  • [8] Local constraints in either the GluN1 or GluN2 subunit equally impair NMDA receptor pore opening
    Talukder, Iehab
    Wollmuth, Lonnie P.
    JOURNAL OF GENERAL PHYSIOLOGY, 2011, 138 (02) : 179 - 194
  • [9] Disease-associated missense mutations in GluN2B subunit alter NMDA receptor ligand binding and ion channel properties
    Fedele, Laura
    Newcombe, Joseph
    Topf, Maya
    Gibb, Alasdair
    Harvey, Robert J.
    Smart, Trevor G.
    NATURE COMMUNICATIONS, 2018, 9
  • [10] Desensitization of NMDA channels requires ligand binding to both GluN1 and GluN2 subunits to constrict the pore beside the activation gate
    Chen, Yu-Shian
    Tu, Ya-Chi
    Lai, Yi-Chen
    Liu, Erin
    Yang, Ya-Chin
    Kuo, Chung-Chin
    JOURNAL OF NEUROCHEMISTRY, 2020, 153 (05) : 549 - 566